Rothschild & Cie
3
24M
3
1
- Areas of investment
Summary
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Rothschild & Cie, startups are often financed by Venrock, Skyline Ventures, Mayfield Fund. The meaningful sponsors for the fund in investment in the same round are bioMerieux, Warburg Pincus, Venrock. In the next rounds fund is usually obtained by Scottish Equity Partners, Warburg Pincus, Rothschild & Co..
Deals in the range of 10 - 50 millions dollars are the general things for fund. This Rothschild & Cie works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2000. The top amount of exits for fund were in 2005. The average startup value when the investment from Rothschild & Cie is 10-50 millions dollars. The fund is constantly included in less than 2 deals per year.
Among the various public portfolio startups of the fund, we may underline ip.access, Sunesis Pharmaceuticals, MEDoctor The fund has exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular fund investment industries, there are Pharmaceutical, Home Health Care.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Investments by industry
- Health Care (2)
- Pharmaceutical (1)
- Biotechnology (1)
- Software (1)
- Mobile (1) Show 2 more
- Investments by region
-
- United States (2)
- United Kingdom (1)
- Peak activity year
- 2000
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Avg. valuation at time of investment
- 3M
- Group Appearance index
- 1.00
- Avg. company exit year
- 20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| MEDoctor | 01 Aug 2000 | Health Care, Home Health Care | Seed | 3M | United States, Wilmington, Delaware |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.